120 related articles for article (PubMed ID: 7930761)
1. Relationship between cytosol TPS, TPA and cell proliferation.
Gion M; Mione R; Becciolini A; Balzi M; Correale M; Piffanelli A; Giovannini G; Saccani Jotti G; Fontanesi M
Int J Biol Markers; 1994; 9(2):109-14. PubMed ID: 7930761
[TBL] [Abstract][Full Text] [Related]
2. Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.
Gion M; Mione R; Gatti C; Dittadi R; Leon A; Castiglioni C; Nascimben O; Bruscagnin G
Breast Cancer Res Treat; 1990 Nov; 17(1):15-21. PubMed ID: 1965704
[TBL] [Abstract][Full Text] [Related]
3. Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue.
Gion M; Mione R; Barioli P; Sartorello P; Capitanio G
Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):779-87. PubMed ID: 7865616
[TBL] [Abstract][Full Text] [Related]
4. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].
Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A
Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070
[TBL] [Abstract][Full Text] [Related]
5. Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator.
Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Brandes A; Vinante O; Bruscagnin G
Eur J Cancer; 1992; 29A(1):66-9. PubMed ID: 1445748
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
[TBL] [Abstract][Full Text] [Related]
7. Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis.
Gion M; Boracchi P; Dittadi R; Biganzoli E; Peloso L; Gatti C; Paccagnella A; Rosabian A; Vinante O; Meo S
Breast Cancer Res Treat; 2000 Feb; 59(3):211-21. PubMed ID: 10832591
[TBL] [Abstract][Full Text] [Related]
8. TPA-cyk assay in cytosol from primary breast cancer: preliminary results.
Correale M; Tedone T; Abbate I; Zotti P; Nassi A; Paradiso A; Schittulli F; De Lena M
Int J Biol Markers; 1994; 9(4):264-5. PubMed ID: 7530753
[No Abstract] [Full Text] [Related]
9. Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.
Gion M; Mione R; Gatti C; Dittadi R; Leon A; Nascimben O; Pizzorno B; Bruscagnin G
Tumori; 1990 Aug; 76(4):360-4. PubMed ID: 2399565
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer.
Trevisani L; Putinati S; Sartori S; Abbasciano V; Bagni B
Chest; 1996 Jan; 109(1):104-8. PubMed ID: 8549168
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of thymidine kinase and tissue polypeptide specific antigen in breast cancer.
Mansour O; Motawi T; Khaled H; el-Ahmady O
Dis Markers; 1993 Nov; 11(4):171-7. PubMed ID: 8112021
[TBL] [Abstract][Full Text] [Related]
12. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen.
Correale M; Arnberg H; Blockx P; Bombardieri E; Castelli M; Encabo G; Gion M; Klapdor R; Martin M; Nilsson S
Int J Biol Markers; 1994; 9(4):231-8. PubMed ID: 7836801
[TBL] [Abstract][Full Text] [Related]
13. The Role of TPS and TPA in the Diagnostics of Distant Metastases.
Kucera R; Topolcan O; Fiala O; Kinkorova J; Treska V; Zedníková I; Slouka D; Simanek V; Safanda M; Babuska V
Anticancer Res; 2016 Feb; 36(2):773-7. PubMed ID: 26851038
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen, ferritin, tissue polypeptide antigen, and CA15/3 in breast cancer: relationship between carcinoma and normal breast tissue.
Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valsecchi M; Del Maschio O; Bruscagnin G
Int J Biol Markers; 1986; 1(1):33-8. PubMed ID: 3480322
[TBL] [Abstract][Full Text] [Related]
17. Plasma and tissue CEA and TPA markers in operable breast cancer. Preliminary results.
Saccani Jotti G; Bombardieri E; Fontanesi M; Becchi G; Bocchi P; Palli D; Rusca M; Rusconi A; Pizzorno B; Tardini A
Tumori; 1988 Dec; 74(6):681-8. PubMed ID: 3232213
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of measuring serum CA 15-3, TPA, and TPS in women with breast cancer.
Sliwowska I; Kopczyński Z; Grodecka-Gazdecka S
Postepy Hig Med Dosw (Online); 2006; 60():295-9. PubMed ID: 16767053
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of TPS, TPA and CA 19-9 measurement in pancreatic cancer.
Plebani M; Basso D; Del Favero G; Ferrara C; Meggiato T; Fogar P; Mangano F; Ricciardi G; Burlina A
Oncology; 1993; 50(6):436-40. PubMed ID: 8233283
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.
Kornek G; Schenk T; Raderer M; Djavarnmad M; Scheithauer W
Br J Cancer; 1995 Jan; 71(1):182-5. PubMed ID: 7529527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
